Scott And White Memorial Hospital
- Type
- Teaching hospital
- Where
- Temple, TX
- Medicare CCN
- 450054
- Received
- $445,059 in 96 records, 2025 ($181,730 general, $263,329 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: SCOTT & WHITE MEMORIAL HOSPITAL Fuzzy (name and state)
- Nonprofit contractor: Scott & White Memorial Hospital Fuzzy (name and state)
- Federal award recipient: SCOTT & WHITE MEMORIAL HOSPITAL Fuzzy (name and state)
- Nonprofit: SCOTT & WHITE MEMORIAL HOSPITAL Fuzzy (name and state)
- Patent assignee: Scott & White Memorial Hospital Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 71 | $181,730 |
| 2025 | Research payment | 25 | $263,329 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Intuitive Surgical, Inc. | 12 | $113,000 | 2025 |
| Abbott Laboratories | 6 | $111,576 | 2025 |
| W. L. Gore & Associates, Inc. | 16 | $92,452 | 2025 |
| MIMEDX Group, Inc. | 26 | $50,100 | 2025 |
| Siemens Medical Solutions USA, Inc. | 1 | $39,000 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 2 | $16,730 | 2025 |
| Stryker Corporation | 8 | $6,698 | 2025 |
| ABBVIE INC. | 3 | $3,743 | 2025 |
| Fisher Scientific Company L.L.C. | 12 | $3,447 | 2025 |
| National Marrow Donor Program | 4 | $3,260 | 2025 |
| Medical Device Business Services, Inc. | 2 | $1,700 | 2025 |
| OrthoPediatrics Corp. | 1 | $1,500 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $650 | 2025 |
| SANOFI-AVENTIS U.S. LLC | 1 | $600 | 2025 |
| PFIZER INC. | 1 | $600 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 25 | $263,329 |
| Long term medical supply or device loan | 17 | $115,666 |
| Consulting Fee | 27 | $51,600 |
| Grant | 4 | $4,887 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 5 | $3,860 |
| Debt forgiveness | 2 | $3,092 |
| Space rental or facility fees (teaching hospital only) | 5 | $1,424 |
| Gift | 11 | $1,199 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Intuitive Surgical, Inc. | $19,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-12-31 | Intuitive Surgical, Inc. | $5,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-12-31 | Intuitive Surgical, Inc. | $4,250 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-12-31 | Fisher Scientific Company L.L.C. | $2,248 | Debt forgiveness (2 payments) | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $1,088 | Long term medical supply or device loan | In-kind items and services | PRIME Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Stryker Corporation | $1,082 | Long term medical supply or device loan | In-kind items and services | Connected OR Hub Device, ENDOSCOPY | 2025 | |
| 2025-12-31 | Stryker Corporation | $843 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $311 | Long term medical supply or device loan | In-kind items and services | SPY-PHI System Device, ENDOSCOPY | 2025 | |
| 2025-12-31 | Stryker Corporation | $181 | Long term medical supply or device loan | In-kind items and services | PRIME TC Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Stryker Corporation | $3 | Long term medical supply or device loan | In-kind items and services | PROCUITY Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-24 | W. L. Gore & Associates, Inc. | $2,925 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-12-12 | W. L. Gore & Associates, Inc. | $3,393 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-12-12 | W. L. Gore & Associates, Inc. | $500 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-12-03 | Medical Device Business Services, Inc. | $500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-12-02 | MIMEDX Group, Inc. | $3,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-02 | MIMEDX Group, Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-01 | W. L. Gore & Associates, Inc. | $7,940 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-11-21 | W. L. Gore & Associates, Inc. | $3,191 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-11-06 | Abbott Laboratories | $112 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-06 | Abbott Laboratories | $31 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | MIMEDX Group, Inc. | $2,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | MIMEDX Group, Inc. | $1,100 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-27 | Fisher Scientific Company L.L.C. | $208 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-27 | Fisher Scientific Company L.L.C. | $125 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-27 | Fisher Scientific Company L.L.C. | $29 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $208 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $125 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $125 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $125 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $96 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $73 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $54 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Fisher Scientific Company L.L.C. | $29 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-17 | National Marrow Donor Program | $685 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-05 | Abbott Laboratories | $31 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-10-01 | MIMEDX Group, Inc. | $3,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-01 | MIMEDX Group, Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | Intuitive Surgical, Inc. | $19,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-30 | Intuitive Surgical, Inc. | $5,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-30 | Intuitive Surgical, Inc. | $4,250 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-26 | Stryker Corporation | $1,197 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-09-23 | Abbott Laboratories | $44,115 | Research payment | Cash or cash equivalent | ALINITY Device, Core Diagnostics | ISM2503029A--Alinity h-series Body Fluid Clinical Study Protocol | 2025 |
| 2025-09-09 | W. L. Gore & Associates, Inc. | $4,423 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-09-09 | W. L. Gore & Associates, Inc. | $2,500 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Post-Approval Study | 2025 |
| 2025-09-03 | MIMEDX Group, Inc. | $2,800 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-03 | MIMEDX Group, Inc. | $1,400 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-26 | ABBVIE INC. | $3,210 | Research payment | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) | 2025 |
| 2025-08-22 | Stryker Corporation | $1,990 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-08-05 | Medical Device Business Services, Inc. | $1,200 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-08-04 | MIMEDX Group, Inc. | $2,800 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-04 | MIMEDX Group, Inc. | $1,400 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-25 | National Marrow Donor Program | $495 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-17 | PFIZER INC. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PENBRAYA Biological, VACCINES | 2025 | |
| 2025-07-15 | W. L. Gore & Associates, Inc. | $11,076 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-07-15 | SANOFI-AVENTIS U.S. LLC | $600 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-07-07 | W. L. Gore & Associates, Inc. | $7,676 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-07-02 | MIMEDX Group, Inc. | $2,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-02 | MIMEDX Group, Inc. | $2,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-02 | MIMEDX Group, Inc. | $1,100 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-02 | MIMEDX Group, Inc. | $1,100 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-30 | Intuitive Surgical, Inc. | $19,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-30 | Intuitive Surgical, Inc. | $5,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-30 | Intuitive Surgical, Inc. | $4,250 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-27 | W. L. Gore & Associates, Inc. | $27,900 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Post-Approval Study | 2025 |
| 2025-06-18 | W. L. Gore & Associates, Inc. | $4,972 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-06-17 | W. L. Gore & Associates, Inc. | $136 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-06-02 | MIMEDX Group, Inc. | $2,600 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-02 | W. L. Gore & Associates, Inc. | $2,000 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-06-02 | MIMEDX Group, Inc. | $1,300 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-02 | ABBVIE INC. | $500 | Research payment | Cash or cash equivalent | HUMIRA Biological, IMMUNOLOGY | A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) | 2025 |
| 2025-05-01 | MIMEDX Group, Inc. | $1,200 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-01 | MIMEDX Group, Inc. | $600 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-25 | National Marrow Donor Program | $1,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-21 | E.R. Squibb & Sons, L.L.C. | $16 | Research payment | Cash or cash equivalent | A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING CC-92480 (BMS-986348), CARFILZOMIB AND DEXAMET | 2025 | |
| 2025-04-11 | Siemens Medical Solutions USA, Inc. | $39,000 | Research payment | Cash or cash equivalent | ADVIA Centaur XP Analyzer Device, DX - Diagnostics incl. all products and services | Atellica CI hsPSA fPSA External Verification Studies | 2025 |
| 2025-04-09 | Abbott Laboratories | $13,800 | Research payment | Cash or cash equivalent | ALINITY Device, Core Diagnostics | ISM2503029A--Alinity h-series Body Fluid Clinical Study Protocol | 2025 |
| 2025-04-04 | Abbott Laboratories | $53,487 | Research payment | Cash or cash equivalent | ALINITY Device, Core Diagnostics | ISM2512040A-Studies T688-02-23B08-01, 09XN-02-24B03-01 | 2025 |
| 2025-04-02 | MIMEDX Group, Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-02 | MIMEDX Group, Inc. | $1,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-31 | Intuitive Surgical, Inc. | $19,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-03-31 | Intuitive Surgical, Inc. | $5,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-03-31 | Intuitive Surgical, Inc. | $4,250 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-03-25 | W. L. Gore & Associates, Inc. | $8,151 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-03-03 | MIMEDX Group, Inc. | $4,200 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-03-03 | MIMEDX Group, Inc. | $2,100 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-02-19 | OrthoPediatrics Corp. | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-07 | W. L. Gore & Associates, Inc. | $2,000 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-02-04 | MIMEDX Group, Inc. | $4,000 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-02-04 | MIMEDX Group, Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-01-31 | W. L. Gore & Associates, Inc. | $3,666 | Research payment | Cash or cash equivalent | GORE CARDIOFORM Septal Occluder Device, Devices | GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with P | 2025 |
| 2025-01-24 | National Marrow Donor Program | $985 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-01-21 | E.R. Squibb & Sons, L.L.C. | $16,714 | Research payment | Cash or cash equivalent | SOTYKTU Drug, Immunology | A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With | 2025 |
| 2025-01-03 | MIMEDX Group, Inc. | $1,200 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-01-03 | Takeda Pharmaceuticals U.S.A., Inc. | $650 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-01-03 | MIMEDX Group, Inc. | $600 | Consulting Fee | Cash or cash equivalent | BOVINE COLLAGEN Device, WOUND CARE | 2025 | |
| 2025-01-03 | ABBVIE INC. | $33 | Research payment | Cash or cash equivalent | A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric P | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Temple, TX, county Bell County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Temple, TX | County Bell County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 89,602 | 386,897 | 30,188,424 |
| Population, 2020 census P1 | 82,073 | 370,647 | 29,145,505 |
| Median age B01002 | 33.8 | 32.3 | 35.6 |
| Under 18 B01001 | 26.6% | 27.5% | 25.0% |
| 65 and over B01001 | 15.1% | 11.9% | 13.4% |
| Households B11001 | 34,514 | 142,305 | 10,992,816 |
| Foreign born B05002 | 8.2% | 8.6% | 17.6% |
| Median household income B19013 | $68,204 | $68,865 | $78,476 |
| Median family income B19113 | $86,005 | $81,043 | $94,599 |
| Per capita income B19301 | $34,319 | $34,279 | $40,752 |
| Poverty rate B17001 | 16.0% | 14.5% | 13.8% |
| Unemployment rate B23025 | 6.6% | 6.8% | 5.3% |
| Civilian labor force B23025 | 42,457 | 170,572 | 15,233,563 |
| Mean commute (minutes) B08013 | 21.0 | 23.9 | 26.7 |
| Bachelor's degree or higher B15003 | 30.6% | 27.2% | 33.8% |
| Housing units B25001 | 37,299 | 155,018 | 12,128,515 |
| Owner-occupied B25003 | 52.3% | 56.5% | 62.6% |
| Renters B25003 | 47.7% | 43.5% | 37.4% |
| Median home value B25077 | $239,000 | $241,000 | $283,800 |
| Median gross rent B25064 | $1,231 | $1,224 | $1,403 |
| White, not Hispanic B03002 | 51.4% | 42.4% | 39.1% |
| Black B03002 | 12.1% | 21.5% | 11.9% |
| Hispanic or Latino B03002 | 29.0% | 26.3% | 39.7% |
| Asian B03002 | 2.0% | 2.9% | 5.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Temple, TX.
Comments